Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity

Mostrar otras versiones (1)

Rhabdoviruses (RVs) are currently being pursued as anticancer therapeutics for various tumor types, notably leukemia. However, modest virion production and limited spread between noncontiguous circulating leukemic cells requires high-dose administration of RVs, which exceeds the maximum tolerable do...

Descripción completa

Detalles Bibliográficos
Autores principales: Batenchuk, C, Le Boeuf, F, Stubbert, L, Falls, T, Atkins, H L, Bell, J C, Conrad, D P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730201/
https://www.ncbi.nlm.nih.gov/pubmed/23852158
http://dx.doi.org/10.1038/bcj.2013.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730201/
https://www.ncbi.nlm.nih.gov/pubmed/23852158
http://dx.doi.org/10.1038/bcj.2013.23

Ejemplares similares